Lv31
300 积分 2024-03-25 加入
Preclinical development of a bispecific TNFα/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease
25天前
已完结
Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor
2个月前
已关闭
Photocontrolled DNA Binding of a Receptor-Targeted Organometallic Ruthenium(II) Complex
2个月前
已完结
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
4个月前
已完结
Translational PET Imaging of Nectin-4 Expression in Multiple Different Cancers with68Ga-N188
4个月前
已完结
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
4个月前
已完结
Advancing Global Nuclear Medicine: The Role and Future Contributions of China
4个月前
已完结
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
5个月前
已完结
BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors
5个月前
已完结
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development
5个月前
已完结
皖公网安备34019202002308
